US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Definium Therapeutics

38.89

+1.163.07%

Post-market: 39.000.1100+0.28%19:55 EDT

Volume:1.75M

Turnover:68.13M

Market Cap:5.23B

PE:-11.17

High:39.37

Open:37.73

Low:37.73

Close:37.73

52wk High:49.70

52wk Low:8.77

Shares:134.37M

Float Shares:131.11M

Volume Ratio:1.28

T/O Rate:1.34%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.4823

EPS(LYR):-2.0600

ROE:-64.09%

ROA:-20.64%

PB:5.69

PE(LYR):-18.88

Loading ...

Overview Company News Filings

Definium Therapeutics, Inc. Announces Proposed Public Offering

THOMSON REUTERS

Definium Therapeutics Is Maintained at Outperform by Leerink Partners

Top Midday Gainers

MT Newswires Live

Canaccord ups Definium Therapeutics target to $60, calls DT120 ‘solid contender’

Definium Therapeutics rises 55.9%

RBC Capital Adjusts Price Target on Definium Therapeutics to $57 From $36, Maintains Outperform Rating

MT Newswires Live

Brisebois Raises Definium Therapeutics Price Target to $63 on Strong DT120 ODT Phase 3 Data and Reduced MDD/GAD Risk

Definium Therapeutics price target raised to $60 from $40 at Oppenheimer

Definium Therapeutics price target raised to $57 from $36 at RBC Capital

Definium Therapeutics Stock (DFTX) Rockets on a Phase 3 Trial Win

RBC Capital says would buy Definium Therapeutics after Phase III data

Definium Therapeutics DT120 data exceeds expectations, says Stifel

Definium Therapeutics Shares Jump on Strong Depression Drug Phase 3 Results

Definium Therapeutics Reports Positive Phase 3 DT120 Results

BUZZ-U.S. STOCKS ON THE MOVE- Visteon, Incyte, Apogee

BUZZ-Definium Therapeutics jumps as depression drug shows positive late-stage trial data

Definium's LSD-based depression pill delivers strong late-stage results, shares surge

Definium Therapeutics announces Emerge met primary endpoint

Definium Therapeutic Shares up 18.5% Premarket After Co's Lsd-Based Pill Reduces Depression Symptoms in Late-Stage Trial

THOMSON REUTERS

Definium Therapeutics - Phase 3 Emerge Study Meets Primary and All Key Secondary Efficacy Endpoints

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/DFTX/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DFTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DFTX\",,,,,undefined,":{"symbol":"DFTX","market":"US","secType":"STK","nameCN":"Definium Therapeutics","latestPrice":38.89,"timestamp":1789156800000,"preClose":37.73,"halted":0,"volume":1754315,"hourTrading":{"tag":"盘后","latestPrice":39,"preClose":38.89,"latestTime":"19:55 EDT","volume":348208,"amount":13541995.6704,"timestamp":1789170913353,"change":0.11,"changeRate":0.002828,"amplitude":0.016804},"delay":0,"changeRate":0.03074476543864309,"floatShares":131114280,"shares":134366950,"eps":-3.482311,"marketStatus":"Market Closed","change":1.16,"latestTime":"09-11 16:00:00 EDT","open":37.73,"high":39.37,"low":37.73,"amount":68131498.355375,"amplitude":0.043467,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.482311,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":37.73,"preHourTrading":{"tag":"盘前","latestPrice":37.9852,"preClose":37.73,"latestTime":"09:18 EDT","volume":4465,"amount":169832.67781,"timestamp":1789132705128,"change":0.2552,"changeRate":0.006764,"amplitude":0.020448},"postHourTrading":{"tag":"盘后","latestPrice":39,"preClose":38.89,"latestTime":"19:55 EDT","volume":348208,"amount":13541995.6704,"timestamp":1789170913353,"change":0.11,"changeRate":0.002828,"amplitude":0.016804},"volumeRatio":1.281823,"impliedVol":1.3321,"impliedVolPercentile":0.8963},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DFTX\",,,,,undefined,":{"symbol":"DFTX","floatShares":131114280,"roa":"-20.64%","roe":"-64.09%","lyrEps":-2.059999,"volumeRatio":1.281823,"shares":134366950,"dividePrice":0,"high":39.37,"amplitude":0.043467,"preClose":37.73,"low":37.73,"week52Low":8.7732,"pbRate":"5.69","week52High":49.7,"institutionHeld":0,"latestPrice":38.89,"eps":-3.482311,"divideRate":0,"volume":1754315,"delay":0,"ttmEps":-3.482311,"open":37.73,"prevYearClose":13.39,"prevWeekClose":38.09,"prevMonthClose":39.72,"prevQuarterClose":47.04,"fiveDayClose":38,"twentyDayClose":43.9,"sixtyDayClose":24.16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DFTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"DFTX","fiscalQuarterEnding":"2026/06","expectedEps":-0.55,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"post","actualEps":-1.44},{"market":"US","date":"2026-05-07","symbol":"DFTX","fiscalQuarterEnding":"2026/03","expectedEps":-0.47,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":-0.71},{"market":"US","date":"2026-02-26","symbol":"DFTX","fiscalQuarterEnding":"2025/12","expectedEps":-0.45,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"post","actualEps":-0.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DFTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DFTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3889,"buy":0.6111,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6111,"analysts":18,"updateTime":1787025600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DFTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DFTX","date":"2026-09-10","current":-11.167871,"percent":0.333333,"low":-27.074722,"twenty":-17.284419,"median":-11.174427,"eighty":-9.903787,"high":-8.802064,"avg":-13.930508,"sd":5.418718,"marketCap":5104600430},"quantilePoints":[{"date":"2026-01-16","current":-9.013032,"twenty":-8.970838,"median":-8.907548,"eighty":-8.844258,"marketCap":1515072711},{"date":"2026-01-23","current":-9.944809,"twenty":-9.944809,"median":-9.423248,"eighty":-8.819645,"marketCap":1671702464},{"date":"2026-01-30","current":-10.103035,"twenty":-10.103035,"median":-9.868626,"eighty":-9.013032,"marketCap":1698299969},{"date":"2026-02-06","current":-9.522872,"twenty":-10.196799,"median":-9.918438,"eighty":-9.522872,"marketCap":1600775783},{"date":"2026-02-13","current":-9.511152,"twenty":-10.179218,"median":-9.944809,"eighty":-9.522872,"marketCap":1598805598},{"date":"2026-02-20","current":-10.120616,"twenty":-10.18039,"median":-9.944809,"eighty":-9.520528,"marketCap":1701255248},{"date":"2026-02-27","current":-9.267085,"twenty":-10.187422,"median":-9.96239,"eighty":-9.520528,"marketCap":1703225433},{"date":"2026-03-06","current":-9.519961,"twenty":-10.18039,"median":-9.903787,"eighty":-9.502065,"marketCap":1749702163},{"date":"2026-03-13","current":-9.753213,"twenty":-10.18039,"median":-9.918437,"eighty":-9.518199,"marketCap":1792572359},{"date":"2026-03-20","current":-10.122078,"twenty":-10.169841,"median":-9.903787,"eighty":-9.52229,"marketCap":1860367087},{"date":"2026-03-27","current":-10.273963,"twenty":-10.169841,"median":-9.918437,"eighty":-9.559599,"marketCap":1888282563},{"date":"2026-04-02","current":-11.174427,"twenty":-10.181562,"median":-9.918437,"eighty":-9.550417,"marketCap":2053781457},{"date":"2026-04-10","current":-11.619234,"twenty":-10.247114,"median":-9.944809,"eighty":-9.57529,"marketCap":2135533923},{"date":"2026-04-17","current":-12.18338,"twenty":-10.396104,"median":-9.980506,"eighty":-9.589394,"marketCap":2239219977},{"date":"2026-04-24","current":-12.617338,"twenty":-11.167918,"median":-10.038572,"eighty":-9.618687,"marketCap":2318978480},{"date":"2026-05-01","current":-11.86876,"twenty":-11.389236,"median":-10.10442,"eighty":-9.643639,"marketCap":2181395062},{"date":"2026-05-08","current":-13.767387,"twenty":-11.71579,"median":-10.122078,"eighty":-9.665202,"marketCap":2530349365},{"date":"2026-05-15","current":-9.802755,"twenty":-11.643102,"median":-10.113211,"eighty":-9.689477,"marketCap":2328575817},{"date":"2026-05-22","current":-10.399644,"twenty":-11.570414,"median":-10.105791,"eighty":-9.636028,"marketCap":2470362634},{"date":"2026-05-29","current":-10.780735,"twenty":-11.483622,"median":-10.120616,"eighty":-9.642537,"marketCap":2560888064},{"date":"2026-06-05","current":-11.290386,"twenty":-11.393576,"median":-10.145827,"eighty":-9.660184,"marketCap":2681952193},{"date":"2026-06-12","current":-11.069996,"twenty":-11.344489,"median":-10.179218,"eighty":-9.68473,"marketCap":2629600138},{"date":"2026-06-18","current":-11.216923,"twenty":-11.349156,"median":-10.196799,"eighty":-9.702279,"marketCap":2664501508},{"date":"2026-06-26","current":-20.565124,"twenty":-11.510745,"median":-10.247973,"eighty":-9.723056,"marketCap":4885101210},{"date":"2026-07-02","current":-24.252692,"twenty":-11.77112,"median":-10.299843,"eighty":-9.753213,"marketCap":5761057223},{"date":"2026-07-10","current":-27.074722,"twenty":-12.069466,"median":-10.333633,"eighty":-9.796609,"marketCap":6431410656},{"date":"2026-07-17","current":-24.643864,"twenty":-12.519698,"median":-10.492938,"eighty":-9.802755,"marketCap":5853977501},{"date":"2026-07-24","current":-23.990048,"twenty":-12.931958,"median":-10.537388,"eighty":-9.812883,"marketCap":5698667894},{"date":"2026-07-31","current":-24.861803,"twenty":-14.440728,"median":-10.67054,"eighty":-9.817222,"marketCap":5905747370},{"date":"2026-08-07","current":-17.312135,"twenty":-19.588062,"median":-10.789918,"eighty":-9.824231,"marketCap":6124773739},{"date":"2026-08-14","current":-16.673146,"twenty":-17.887875,"median":-10.831241,"eighty":-9.831914,"marketCap":5898709105},{"date":"2026-08-21","current":-17.242844,"twenty":-17.526933,"median":-11.058518,"eighty":-9.861594,"marketCap":6100259530},{"date":"2026-08-28","current":-16.642763,"twenty":-17.426666,"median":-11.092954,"eighty":-9.887379,"marketCap":5887959749},{"date":"2026-09-04","current":-14.432336,"twenty":-17.33018,"median":-11.139168,"eighty":-9.901443,"marketCap":5105944100},{"date":"2026-09-10","current":-14.428538,"twenty":-17.284419,"median":-11.174427,"eighty":-9.903787,"marketCap":5104600430}],"updateTime":1789173568626},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DFTX\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2645007798","title":"Definium Therapeutics, Inc. Announces Proposed Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2645007798","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645007798?lang=en_us&edition=fundamental","pubTime":"2026-06-23 04:01","pubTimestamp":1782158460,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nTUAWSFYZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645071091","title":"Definium Therapeutics Is Maintained at Outperform by Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2645071091","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645071091?lang=en_us&edition=fundamental","pubTime":"2026-06-23 02:10","pubTimestamp":1782151800,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DFTX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 22, 2026 14:10 ET (18:10 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645071067","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2645071067","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645071067?lang=en_us&edition=fundamental","pubTime":"2026-06-23 02:07","pubTimestamp":1782151648,"startTime":"0","endTime":"0","summary":"Nexentis Technologies  said Monday its subsidiary, MitoCareX Bio, has entered into an engagement with Boltz, an AI research lab, to accelerate the identification of novel small-molecule scaffolds targeting selected solute carrier proteins of interest to MitoCareX's pipeline.Shares jumped over 200% as trading volume catapulted to over 55 million from a daily average of about 208,000.AbbVie  agreed to acquire Apogee Therapeutics  for $135.11 per share in cash for a total equity value of $10.9 billion, the companies said Monday.Shares of Apogee soared 47%, with intraday trading volume of over 47.1 million against a daily average of about 975,000.Definium Therapeutics  reported positive topline results from a phase 3 Emerge study of DT120 orally disintegrating tablet in major depressive disorder.RBC Capital raised its price target to $57 from $36, while maintaining its outperform rating.Shares surged 52% amid a jump in intraday trading volume to over 16 million from a daily average of roug","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ABBV","LU0211327993.USD","LU1934455277.USD","LU0859254822.USD","LU1244550577.SGD","LU0868494617.USD","LU1934455194.USD","LU1934455863.HKD","IE000F7OJYX1.SGD","LU2089283258.USD","IE000SO60NU8.SGD","LU2237443549.SGD","BK4585","LU1162221912.USD","IE0000B7K699.USD","LU0256863902.USD","LU0545039389.USD","LU0985320562.USD","LU1291159041.SGD","IE00BJJMRZ35.SGD","LU0211328371.USD","IE00B42XCP33.USD","LU0795875086.SGD","IE00B4R5TH58.HKD","LU2023251221.USD","LU0069063385.USD","LU1551013425.SGD","IE00BSNM7G36.USD","LU0456855351.SGD","SG9999011175.SGD","LU1983299246.USD","IE00B3PB1722.GBP","BK4533","LU0553294199.USD","LU0868494708.USD","BK4566","IE00BBT3K403.USD","LU1718418525.SGD","LU0661504455.SGD","LU0170899867.USD","LU2133065610.SGD","LU1074936037.SGD","IE00BFTCPJ56.SGD","LU2468319806.SGD","LU1839511570.USD","NXTS","LU0708994859.HKD","DFTX","APGE","IE00BDGV0183.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645074587","title":"Canaccord ups Definium Therapeutics target to $60, calls DT120 ‘solid contender’","url":"https://stock-news.laohu8.com/highlight/detail?id=2645074587","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645074587?lang=en_us&edition=fundamental","pubTime":"2026-06-23 02:05","pubTimestamp":1782151507,"startTime":"0","endTime":"0","summary":"As previously reported, Canaccord raised the firm’s price target on Definium Therapeutics (DFTX) to $60 from $38 and keeps a Buy rating on the shar...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/canaccord-ups-definium-therapeutics-target-to-60-calls-dt120-solid-contender-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/canaccord-ups-definium-therapeutics-target-to-60-calls-dt120-solid-contender-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645798160","title":"Definium Therapeutics rises 55.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645798160","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645798160?lang=en_us&edition=fundamental","pubTime":"2026-06-23 00:11","pubTimestamp":1782144688,"startTime":"0","endTime":"0","summary":"Definium Therapeutics (DFTX) is up 55.9%, or $13.68 to $38.16. Published first on TheFly – the ultimate source for real-time, market-moving breakin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-rises-55-9-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-rises-55-9-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645076458","title":"RBC Capital Adjusts Price Target on Definium Therapeutics to $57 From $36, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2645076458","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645076458?lang=en_us&edition=fundamental","pubTime":"2026-06-23 00:01","pubTimestamp":1782144071,"startTime":"0","endTime":"0","summary":"Definium Therapeutics, Inc. (DFTX) has an average rating of buy and mean price target of $42, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645076482","title":"Brisebois Raises Definium Therapeutics Price Target to $63 on Strong DT120 ODT Phase 3 Data and Reduced MDD/GAD Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2645076482","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645076482?lang=en_us&edition=fundamental","pubTime":"2026-06-22 23:55","pubTimestamp":1782143746,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Francois Brisebois has reiterated their bullish stance on DFTX stock, giving a Buy rating today. Francois Brisebois has giv...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/brisebois-raises-definium-therapeutics-price-target-to-63-on-strong-dt120-odt-phase-3-data-and-reduced-mdd-gad-risk-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/brisebois-raises-definium-therapeutics-price-target-to-63-on-strong-dt120-odt-phase-3-data-and-reduced-mdd-gad-risk-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX","ABVC","ODT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645076141","title":"Definium Therapeutics price target raised to $60 from $40 at Oppenheimer","url":"https://stock-news.laohu8.com/highlight/detail?id=2645076141","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645076141?lang=en_us&edition=fundamental","pubTime":"2026-06-22 23:41","pubTimestamp":1782142915,"startTime":"0","endTime":"0","summary":"Oppenheimer raised the firm’s price target on Definium Therapeutics (DFTX) to $60 from $40 and keeps an Outperform rating on the shares. Published ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-price-target-raised-to-60-from-40-at-oppenheimer-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-price-target-raised-to-60-from-40-at-oppenheimer-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OPY","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645763780","title":"Definium Therapeutics price target raised to $57 from $36 at RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2645763780","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645763780?lang=en_us&edition=fundamental","pubTime":"2026-06-22 23:35","pubTimestamp":1782142507,"startTime":"0","endTime":"0","summary":"Following Definium Therapeutics (DFTX)’ call detailing the Phase 3 results from the Emerge study, RBC Capital raised the firm’s price target to $57...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-price-target-raised-to-57-from-36-at-rbc-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-price-target-raised-to-57-from-36-at-rbc-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645807310","title":"Definium Therapeutics Stock (DFTX) Rockets on a Phase 3 Trial Win","url":"https://stock-news.laohu8.com/highlight/detail?id=2645807310","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645807310?lang=en_us&edition=fundamental","pubTime":"2026-06-22 22:22","pubTimestamp":1782138120,"startTime":"0","endTime":"0","summary":"Definium Therapeutics stock rallied alongside positive results from a Phase 3 clinical trial.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/definium-therapeutics-stock-dftx-rockets-on-a-phase-3-trial-win?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/definium-therapeutics-stock-dftx-rockets-on-a-phase-3-trial-win?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645907850","title":"RBC Capital says would buy Definium Therapeutics after Phase III data","url":"https://stock-news.laohu8.com/highlight/detail?id=2645907850","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645907850?lang=en_us&edition=fundamental","pubTime":"2026-06-22 21:56","pubTimestamp":1782136590,"startTime":"0","endTime":"0","summary":"Definium Therapeutics (DFTX) reported that the Phase III EMERGE trial for DT120-ODT in major depressive disorder met all primary and secondary endp...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/rbc-capital-says-would-buy-definium-therapeutics-after-phase-iii-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/rbc-capital-says-would-buy-definium-therapeutics-after-phase-iii-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0310800379.SGD","BK4007","LU1267930573.SGD","LU0128525929.USD","LU0708994859.HKD","LU0029864427.USD","BK4134","III","BK4207","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645078682","title":"Definium Therapeutics DT120 data exceeds expectations, says Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2645078682","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645078682?lang=en_us&edition=fundamental","pubTime":"2026-06-22 21:53","pubTimestamp":1782136387,"startTime":"0","endTime":"0","summary":"Stifel says “robust” major depressive disorder data reported by Definium Therapeutics (DFTX) for DT120 “exceeds expectations,” noting that the effe...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-dt120-data-exceeds-expectations-says-stifel-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-dt120-data-exceeds-expectations-says-stifel-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SF","BK4007","DFTX","BK4127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645217022","title":"Definium Therapeutics Shares Jump on Strong Depression Drug Phase 3 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2645217022","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645217022?lang=en_us&edition=fundamental","pubTime":"2026-06-22 20:42","pubTimestamp":1782132120,"startTime":"0","endTime":"0","summary":"Definium Therapeutics shares surged in premarket trading Monday after the company reported strong phase 3 results for its experimental depression treatment.Shares traded 50% higher ahead of the morning bell at $36.74.The late-stage clinical biopharmaceutical company said patients receiving DT120, also known as lysergide, showed an improvement on a standard depression scale at week six, with effects emerging as early as the first week and lasting for up to 12 weeks.The Emerge study met its primary and all key secondary endpoints, including an eight-point placebo-adjusted reduction in symptoms by the sixth week.\"The Emerge topline results represent unprecedented and highly differentiated efficacy, demonstrating that a single dose of DT120 ODT can deliver rapid, robust, and durable relief in major depressive disorder,\" said Chief Executive Rob Barrow.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Definium Therapeutics Shares Jump on Strong Depression Drug Phase 3 Results","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645022295","title":"Definium Therapeutics Reports Positive Phase 3 DT120 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2645022295","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645022295?lang=en_us&edition=fundamental","pubTime":"2026-06-22 20:38","pubTimestamp":1782131897,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Definium Therapeutics ( ($DFTX) ). On June 22, 2026, Definium Therapeutics reported positive topline results fr...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/definium-therapeutics-reports-positive-phase-3-dt120-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/definium-therapeutics-reports-positive-phase-3-dt120-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645024876","title":"BUZZ-U.S. STOCKS ON THE MOVE- Visteon, Incyte, Apogee","url":"https://stock-news.laohu8.com/highlight/detail?id=2645024876","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645024876?lang=en_us&edition=fundamental","pubTime":"2026-06-22 19:54","pubTimestamp":1782129252,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Visteon, Incyte, ApogeeWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https:","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nL6N42U0MK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0323591593.USD","LU2023250330.USD","LU0097036916.USD","TSLP","HOOW","LU2168564065.EUR","BK4563","HOOD","BK4539","IE0034235303.USD","IE00BWXC8680.SGD","LU1852331112.SGD","TESL","LU0082616367.USD","TSYY","LU2471134952.CNY","LU0943347566.SGD","LU2360107168.USD","LU0672654240.SGD","BK4007","LU0133085943.USD","HOOX","LU1435385759.SGD","HOOI","LU0823411888.USD","LU2063271972.USD","IE00BSNM7G36.USD","SG9999015986.USD","LU1778281490.HKD","LU2087621335.USD","LU2357305700.SGD","LU0109391861.USD","LU1145028129.USD","LU2236285917.USD","BK4588","LU2602419157.SGD","TSLT","IE00BJLML261.HKD","LU0820562030.AUD","IE00B1XK9C88.USD","LU0708995401.HKD","IE00B19Z8W00.USD","LU2168564495.EUR","BK4516","TSII","BK4581","BK4598","HK0000914660.USD","LU0719512351.SGD","LU1629891620.HKD","LU0345769631.USD","BK4532","LU2290526834.HKD","BK4533","TSLI","LU0053666078.USD","TSLY","LU2420271590.USD","IE00B1BXHZ80.USD","TSLG","LU1720051108.HKD","IE00B19Z9505.USD","LU0466842654.USD","LU0820561909.HKD","LU1839511570.USD","LU1066053197.SGD","HOOY","LU1429558221.USD","LU0964807845.USD","BK4534","BK4124","LU0056508442.USD","LU0345770993.USD","BK4127","LU1720051017.SGD","BK4527","LU0077335932.USD","LU1066051811.HKD","LU2417539215.USD","LU2756315318.SGD","LU1066051225.USD","LU2471134879.HKD","HOOZ","LU2471134523.USD","LU2250418816.HKD","RGNX","LU0823414478.USD","07366","LU0345770308.USD","LU2168564222.USD","TSLO","LU2213496289.HKD","HOII","LU0234570918.USD","HODU","TSL","CRSH","BK4585","IE00B19Z8X17.USD","TSLQ","BK4574","LU0210536198.USD","BK4213","LU0320765059.SGD","TSLZ","LU2896262040.SGD","BK4548","SG9999015945.SGD","APGE","LU2462157665.USD","IE00BZ199S13.USD","LU1066051498.USD","LU1232071149.USD","TSLA","AVAL","TSLL","LU2456880835.USD","09366","INCY","LU1861220033.SGD","07766","LU2750360641.GBP","BK4612","LU1674673428.USD","ROBN","LU2249611893.SGD","LU1914381329.SGD","LU0316494557.USD","BK4550","BK4139","BK4551","LU1366192091.USD","LU1551013425.SGD","LU2168563687.JPY","09766","LU2403377893.USD","LU2471134796.USD","LU0689472784.USD","BK4547","SG9999015952.SGD","HOYY","BK4099","LU0053671581.USD","BK4604","BK4207","LU0820561818.USD","TEST","BK4511","SG9999015978.USD","LU1861215975.USD","LU2360106780.USD","DFTX","TSDD","BK4555","GPRK","VC","TSLS","LU0234572021.USD","LU0757428866.USD","TLA","LU0345769128.USD","LU1674673691.USD","BK4543","TSLW","HOOG","LU1861559042.SGD","LU2326559502.SGD","LU0348723411.USD","BK4592","LU1551013342.USD","LU2108987350.USD","HK0000914686.HKD","LU0198837287.USD","IE00BK4W5M84.HKD","BK4505","LU1815336091.USD","LU2756315664.SGD","LU1548497426.USD","LU2750360997.AUD","IE00BK4W5L77.USD","TSLR","LU1861558580.USD","LU2168564149.EUR","LU1267930730.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645029056","title":"BUZZ-Definium Therapeutics jumps as depression drug shows positive late-stage trial data","url":"https://stock-news.laohu8.com/highlight/detail?id=2645029056","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645029056?lang=en_us&edition=fundamental","pubTime":"2026-06-22 19:13","pubTimestamp":1782126785,"startTime":"0","endTime":"0","summary":"BUZZ-Definium Therapeutics jumps as depression drug shows positive late-stage trial data** Shares of biotech firm Definium Therapeutics DFTX.O rise 19% to $25.02 premarket** Co says DT120, an experimental oral drug for major depressive disorder, a common mental health condition causing persistent low mood, met main goal in late-stage study** Says patients showed 8.1-point greater improvement in depression scores vs placebo after six weeks** DFTX says benefit seen within one week and remained significant at 12 weeks** Says DT120, based on lysergide , was generally well tolerated with no serious safety concerns** Co plans to advance DT120 toward regulatory review; also testing in anxiety and PTSD** As of last close, stock up ~83% YTD  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nL4N42U0RW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645029776","title":"Definium's LSD-based depression pill delivers strong late-stage results, shares surge","url":"https://stock-news.laohu8.com/highlight/detail?id=2645029776","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645029776?lang=en_us&edition=fundamental","pubTime":"2026-06-22 19:11","pubTimestamp":1782126682,"startTime":"0","endTime":"0","summary":"UPDATE 2-Definium's LSD-based depression pill delivers strong late-stage results, shares surgeUpdates share movement, adds analyst comment 6 and 7, background throughoutBy Kamal Choudhury","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nL4N42U0S5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B4R5TH58.HKD","LU2756315664.SGD","SG9999013999.USD","AXSM","IE00BKVL7J92.USD","LU0124676726.USD","LU1496350502.SGD","LU2896262040.SGD","LU2236285917.USD","LU1929549753.HKD","CMPS","JNJ","LU0943347566.SGD","SG9999001176.SGD","LU0432979614.USD","LU1162221912.USD","LU1551013342.USD","LU0210528500.USD","LU1244550494.USD","LU0466842654.USD","LU1244550577.SGD","LU1121112475.USD","LU1196500208.SGD","LU1894683264.USD","BK4550","LU1551013425.SGD","LU0053666078.USD","LU2456880835.USD","IE0001KFT4U8.USD","LU2417539215.USD","LU2430703251.USD","LU1057294990.SGD","LU1043141123.HKD","IE0002270589.USD","LU0689626769.HKD","DFTX","SGXZ57979304.SGD","LU1244550221.USD","IE00BN8TJ469.HKD","SUPN","LU1914381329.SGD","LU2471134952.CNY","BK4585","LU0122379950.USD","LU0345769631.USD","LU0683600562.USD","LU0070217475.USD","LU1778281490.HKD","LU1074936037.SGD","BK4504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645702153","title":"Definium Therapeutics announces Emerge met primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2645702153","media":"TIPRANKS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645702153?lang=en_us&edition=fundamental","pubTime":"2026-06-22 19:08","pubTimestamp":1782126483,"startTime":"0","endTime":"0","summary":"Definium Therapeutics (DFTX) announced positive topline results from Emerge, its first randomized, double-blind, placebo-controlled Phase 3 study e...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-announces-emerge-met-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-announces-emerge-met-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645029259","title":"Definium Therapeutic Shares up 18.5% Premarket After Co's Lsd-Based Pill Reduces Depression Symptoms in Late-Stage Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2645029259","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645029259?lang=en_us&edition=fundamental","pubTime":"2026-06-22 19:07","pubTimestamp":1782126456,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nL4N42U0S3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645296790","title":"Definium Therapeutics - Phase 3 Emerge Study Meets Primary and All Key Secondary Efficacy Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2645296790","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645296790?lang=en_us&edition=fundamental","pubTime":"2026-06-22 19:00","pubTimestamp":1782126001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nTUABJ07L5:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}